1343 related articles for article (PubMed ID: 21506741)
1. A common MUC5B promoter polymorphism and pulmonary fibrosis.
Seibold MA; Wise AL; Speer MC; Steele MP; Brown KK; Loyd JE; Fingerlin TE; Zhang W; Gudmundsson G; Groshong SD; Evans CM; Garantziotis S; Adler KB; Dickey BF; du Bois RM; Yang IV; Herron A; Kervitsky D; Talbert JL; Markin C; Park J; Crews AL; Slifer SH; Auerbach S; Roy MG; Lin J; Hennessy CE; Schwarz MI; Schwartz DA
N Engl J Med; 2011 Apr; 364(16):1503-12. PubMed ID: 21506741
[TBL] [Abstract][Full Text] [Related]
2. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.
Juge PA; Lee JS; Ebstein E; Furukawa H; Dobrinskikh E; Gazal S; Kannengiesser C; Ottaviani S; Oka S; Tohma S; Tsuchiya N; Rojas-Serrano J; González-Pérez MI; Mejía M; Buendía-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou K; van Moorsel CHM; van der Vis J; de Man YA; Grutters JC; Wang Y; Borie R; Wemeau-Stervinou L; Wallaert B; Flipo RM; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Marchand-Adam S; Frazier A; Richette P; Allanore Y; Sibilia J; Dromer C; Richez C; Schaeverbeke T; Lioté H; Thabut G; Nathan N; Amselem S; Soubrier M; Cottin V; Clément A; Deane K; Walts AD; Fingerlin T; Fischer A; Ryu JH; Matteson EL; Niewold TB; Assayag D; Gross A; Wolters P; Schwarz MI; Holers M; Solomon JJ; Doyle T; Rosas IO; Blauwendraat C; Nalls MA; Debray MP; Boileau C; Crestani B; Schwartz DA; Dieudé P
N Engl J Med; 2018 Dec; 379(23):2209-2219. PubMed ID: 30345907
[TBL] [Abstract][Full Text] [Related]
3. Exploration of the MUC5B promoter variant and ILD risk in patients with autoimmune myositis.
Johnson C; Rosen P; Lloyd T; Horton M; Christopher-Stine L; Oddis CV; Mammen AL; Danoff SK
Respir Med; 2017 Sep; 130():52-54. PubMed ID: 29206633
[TBL] [Abstract][Full Text] [Related]
4. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias.
van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH
Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the promoter
Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
[TBL] [Abstract][Full Text] [Related]
6. Overlap of Genetic Risk between Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis.
Hobbs BD; Putman RK; Araki T; Nishino M; Gudmundsson G; Gudnason V; Eiriksdottir G; Zilhao Nogueira NR; Dupuis J; Xu H; O'Connor GT; Manichaikul A; Nguyen J; Podolanczuk AJ; Madahar P; Rotter JI; Lederer DJ; Barr RG; Rich SS; Ampleford EJ; Ortega VE; Peters SP; O'Neal WK; Newell JD; Bleecker ER; Meyers DA; Allen RJ; Oldham JM; Ma SF; Noth I; Jenkins RG; Maher TM; Hubbard RB; Wain LV; Fingerlin TE; Schwartz DA; Washko GR; Rosas IO; Silverman EK; Hatabu H; Cho MH; Hunninghake GM
Am J Respir Crit Care Med; 2019 Dec; 200(11):1402-1413. PubMed ID: 31339356
[No Abstract] [Full Text] [Related]
7. CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism.
Chung JH; Peljto AL; Chawla A; Talbert JL; McKean DF; Rho BH; Fingerlin TE; Schwarz MI; Schwartz DA; Lynch DA
Chest; 2016 May; 149(5):1215-22. PubMed ID: 26836909
[TBL] [Abstract][Full Text] [Related]
8. The pulmonary fibrosis-associated MUC5B promoter polymorphism does not influence the development of interstitial pneumonia in systemic sclerosis.
Peljto AL; Steele MP; Fingerlin TE; Hinchcliff ME; Murphy E; Podlusky S; Carns M; Schwarz M; Varga J; Schwartz DA
Chest; 2012 Dec; 142(6):1584-1588. PubMed ID: 22576636
[TBL] [Abstract][Full Text] [Related]
9.
Mathai SK; Humphries S; Kropski JA; Blackwell TS; Powers J; Walts AD; Markin C; Woodward J; Chung JH; Brown KK; Steele MP; Loyd JE; Schwarz MI; Fingerlin T; Yang IV; Lynch DA; Schwartz DA
Thorax; 2019 Dec; 74(12):1131-1139. PubMed ID: 31558622
[TBL] [Abstract][Full Text] [Related]
10. The MUC5B Promoter Polymorphism is Not Associated With Non-ILD Chronic Respiratory Diseases or Post-transplant Outcome.
Goos T; Verleden SE; De Sadeleer LJ; Van Herck A; Sacreas A; Vanstapel A; Kaes J; Geudens V; Aelbrecht C; Ruttens D; Lambrechts D; Vermeer S; Ceulemans LJ; Van Raemdonck DE; Godinas L; Yserbyt J; Vanaudenaerde BM; Verleden GM; Vos R; Wuyts WA
Transpl Int; 2022; 35():10159. PubMed ID: 35651878
[TBL] [Abstract][Full Text] [Related]
11. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
[TBL] [Abstract][Full Text] [Related]
12. Regulation of MUC5B Expression in Idiopathic Pulmonary Fibrosis.
Helling BA; Gerber AN; Kadiyala V; Sasse SK; Pedersen BS; Sparks L; Nakano Y; Okamoto T; Evans CM; Yang IV; Schwartz DA
Am J Respir Cell Mol Biol; 2017 Jul; 57(1):91-99. PubMed ID: 28272906
[TBL] [Abstract][Full Text] [Related]
13. Mucin 5B promoter polymorphism is associated with susceptibility to interstitial lung diseases in Chinese males.
Wang C; Zhuang Y; Guo W; Cao L; Zhang H; Xu L; Fan Y; Zhang D; Wang Y
PLoS One; 2014; 9(8):e104919. PubMed ID: 25121989
[TBL] [Abstract][Full Text] [Related]
14. MUC5B promoter polymorphism and pulmonary fibrosis.
Zhang GY; Liao T; Gao WY
N Engl J Med; 2011 Jul; 365(2):178; author reply 178-9. PubMed ID: 21751917
[No Abstract] [Full Text] [Related]
15. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
[TBL] [Abstract][Full Text] [Related]
16. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.
Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P
Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872
[TBL] [Abstract][Full Text] [Related]
18. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
[TBL] [Abstract][Full Text] [Related]
19. MUC5B expression and location in surfactant protein C mutations in children.
Liptzin DR; Watson AM; Murphy E; Kroehl ME; Dishop MK; Galambos C; Evans CM; Schwarz MI; Deterding RR; Schwartz DA
Pediatr Pulmonol; 2015 Dec; 50(12):1270-6. PubMed ID: 25858779
[TBL] [Abstract][Full Text] [Related]
20. MUC5B promoter polymorphism and interstitial lung abnormalities.
Hunninghake GM; Hatabu H; Okajima Y; Gao W; Dupuis J; Latourelle JC; Nishino M; Araki T; Zazueta OE; Kurugol S; Ross JC; San José Estépar R; Murphy E; Steele MP; Loyd JE; Schwarz MI; Fingerlin TE; Rosas IO; Washko GR; O'Connor GT; Schwartz DA
N Engl J Med; 2013 Jun; 368(23):2192-200. PubMed ID: 23692170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
